HSP90 HSP70 BIPHENYL AMIDES WITH MODIFIED ETHER GROUPS AS HSP90 INHIBITORS AND HSP70 INDUCERS
하기 화학식 (I)의 화합물이 본 명세서에서 제공된다:식 중, n, X, R, R', R, R', R, R', R및 R'는 본 명세서에서 정의된 바와 같다. 이 화합물의 약제학적 조성물이 또한 제공된다. 몇몇 양상에 있어서, 이러한 화합물은 당뇨성 말초 신경병증 또는 암을 비롯한 질환의 치료를 위하여 이용될 수 있다. Provided herein are compounds of the formulas:wherein: n, X2, R3, R3′, R4, R4′, R5, R5′, R6, and R6′...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
31.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 하기 화학식 (I)의 화합물이 본 명세서에서 제공된다:식 중, n, X, R, R', R, R', R, R', R및 R'는 본 명세서에서 정의된 바와 같다. 이 화합물의 약제학적 조성물이 또한 제공된다. 몇몇 양상에 있어서, 이러한 화합물은 당뇨성 말초 신경병증 또는 암을 비롯한 질환의 치료를 위하여 이용될 수 있다.
Provided herein are compounds of the formulas:wherein: n, X2, R3, R3′, R4, R4′, R5, R5′, R6, and R6′ are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including diabetic peripheral neuropathy or cancer. |
---|---|
AbstractList | 하기 화학식 (I)의 화합물이 본 명세서에서 제공된다:식 중, n, X, R, R', R, R', R, R', R및 R'는 본 명세서에서 정의된 바와 같다. 이 화합물의 약제학적 조성물이 또한 제공된다. 몇몇 양상에 있어서, 이러한 화합물은 당뇨성 말초 신경병증 또는 암을 비롯한 질환의 치료를 위하여 이용될 수 있다.
Provided herein are compounds of the formulas:wherein: n, X2, R3, R3′, R4, R4′, R5, R5′, R6, and R6′ are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including diabetic peripheral neuropathy or cancer. |
Author | DOBROWSKY RICK T ANYIKA MERCY BLAGG BRIAN S.J |
Author_xml | – fullname: BLAGG BRIAN S.J – fullname: ANYIKA MERCY – fullname: DOBROWSKY RICK T |
BookMark | eNrjYmDJy89L5WSI9QgOsDRQAJLmBgpOngEern6RPgqOvp4ursEK4Z4hHgq-_i6ebp6uLgquIR6uQQruQf6hAcEKjsEKEJ2efh6eTp4h_kFAMT8XqEGefi6hzq5BwTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JN47yMjA0NzAwNjU0tDQ0Zg4VQCKfDRm |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | HSP90 저해제 및 HSP70 유도제로서의 개질된 에터기를 가진 바이페닐 아마이드 |
ExternalDocumentID | KR20170035911A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20170035911A3 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 06 06:11:46 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20170035911A3 |
Notes | Application Number: KR20177001978 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170331&DB=EPODOC&CC=KR&NR=20170035911A |
ParticipantIDs | epo_espacenet_KR20170035911A |
PublicationCentury | 2000 |
PublicationDate | 20170331 |
PublicationDateYYYYMMDD | 2017-03-31 |
PublicationDate_xml | – month: 03 year: 2017 text: 20170331 day: 31 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | THE UNIVERSITY OF KANSAS |
RelatedCompanies_xml | – name: THE UNIVERSITY OF KANSAS |
Score | 3.0627625 |
Snippet | 하기 화학식 (I)의 화합물이 본 명세서에서 제공된다:식 중, n, X, R, R', R, R', R, R', R및 R'는 본 명세서에서 정의된 바와 같다. 이 화합물의 약제학적 조성물이 또한 제공된다. 몇몇 양상에 있어서, 이러한 화합물은 당뇨성 말초 신경병증 또는 암을 비롯한... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
Title | HSP90 HSP70 BIPHENYL AMIDES WITH MODIFIED ETHER GROUPS AS HSP90 INHIBITORS AND HSP70 INDUCERS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170331&DB=EPODOC&locale=&CC=KR&NR=20170035911A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKeqbTsXLlIDSt2I3a90ehrRNSuLshbbT-SBjvQiibMNV_PuedJ3uaS8hF3qSnHJyvrQ5XwCu8ky-y2ysSm50VW9nutrpJLhrRayvpbphpIkMcHY9gw_0h-HtsAafy1iYkif0pyRHRItK0d6Lcr2e_X_EouXZyvl18o5V03sn7lGl2h23sEdcVKjVY4FPfVux7V4_VLxw0Sbp6lotcwM2JZCWTPvsyZJxKbNVp-LswVaA8ibFPtQ-pg3YsZd3rzVg261-eWO2sr75AbzyKOhqBNM7jVgi4Mx7eSSmKyiLyLOIOXF9KhzBKGExZyEpz9RHxIzI4knhcWGJ2A-xzqOVIOHRgc3C6BAuHRbbXMVxjv7UMuqHq5O6OYL6ZDrJj4G0EZK8oe_Oc1R4qiHi0JN8nGSIJsZGNzVOoLlO0un65jPYlcVFXF4T6sXXd36OjrlILkp9_gJ7B4fF |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUeMHahMNb4sD54AHYtjapRX2kW0oPhjCPkyMBojM-O97HUN54qVZeumtu-Z6v3a9XwFu0kSOZTJRJDe6ojUTTWm3I1y1ItZXY03X40gmONuOzofa4-h-VILPVS5MzhP6k5MjokfF6O9ZPl_P_zexaH62cnEbvWPV7MEKu7RerI4b-EacVKjRZZ5LXbNumt2-X3f8pUzS1TUavS3Ybkl-XgmengyZlzJfDyrWPux4qG-aHUDpY1aFirm6e60Ku3bxyxsfC-9bHMIrD7yOSrBsqcQQHmfOy4D0bEFZQJ5FyIntUmEJRgkLOfNJfqY-IL2ALFsKhwtDhK6PdQ4tFAmHDk3mB0dwbbHQ5Ar2c_xnlnHfX_-ou2MoT2fT9ARIEyHJG8buNEWDxyoiDi1KJ1GCaGKid2L9FGqbNJ1tFl9BhYf2YDwQTv8c9qRomaNXg3L29Z1eYJDOosvctr_9loqy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HSP90+HSP70+BIPHENYL+AMIDES+WITH+MODIFIED+ETHER+GROUPS+AS+HSP90+INHIBITORS+AND+HSP70+INDUCERS&rft.inventor=BLAGG+BRIAN+S.J&rft.inventor=ANYIKA+MERCY&rft.inventor=DOBROWSKY+RICK+T&rft.date=2017-03-31&rft.externalDBID=A&rft.externalDocID=KR20170035911A |